Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Preparing for the Future of Disaster Health Volunteerism ...
Released: August 15, 2017
The Forum on Medical and Public Health Preparedness for Disasters and Emergencies of the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine convened a 4-hour session at the 2017 Preparedness Summit. The participants discussed potential characteristics of society in the year 2042 and the key resources, tools, and opportunities necessary to support the development of a robust, scalable, and regularly engaged disaster health volunteer workforce prepared for such a future.
Strengthening the Disaster Resilience of the Academic ...
Released: August 10, 2017
The United States has experienced and continues to face the threat of disasters, and, like all entities, the academic biomedical research community can be affected. The academic biomedical research community is a hub of employment, economic productivity, and scientific progress. Given the crucial contribution and substantial integration of these institutions into the national fabric, the National Academies of Sciences, Engineering, and Medicine convened an expert committee to develop recommendations and guidance to enhance the disaster resilience of the academic biomedical research community.
Guiding Principles for Developing Dietary Reference Intakes ...
Released: August 03, 2017
For decades, nutrient intake recommendations have been issued through the Dietary Reference Intakes (DRIs) established by consensus committees of the Institute of Medicine, and now the National Academies of Sciences, Engineering, and Medicine (the National Academies). For each nutrient (e.g., vitamins, minerals, water, electrolytes, carbohydrate, or protein) deemed essential, DRI committees reviews the scientific literature to help inform nutrition standards of adequacy and toxicity for groups of people of different genders and at different life stages. These DRIs are used for planning and assessing the diets of apparently healthy individuals and groups.
The Drug Development Paradigm in Oncology: Proceedings ...
Released: July 24, 2017
Advances in cancer research have led to an improved understanding of the molecular mechanisms underpinning the development of cancer and how the immune system responds to cancer. This influx of research has led to an increasing number and variety of cancer therapies in the drug development pipeline. Compared with standard chemotherapies, these new cancer therapies may demonstrate evidence of benefit at an earlier stage of development.
Building Sustainable Financing Structures for Population ...
Released: July 18, 2017
A workshop held on October 19, 2016 explored financing structures from non-health sectors that provide lessons and examples useful for cross-sector efforts to change community conditions that influence population health. The workshop showcased speakers with expertise in clean energy financing, housing, and justice reinvestment. Presentations and discussion included examples of the ways in which financing approaches (e.g., gain sharing agreements, taxes, credits) can be designed to achieve co-benefits, or win-wins, for health and other domains.
Integrating the Patient and Caregiver Voice into Serious ...
Released: July 14, 2017
Millions of people—infants, children, adults, and their families—are currently coping with serious illness in the United States. Efforts are intensifying to improve overall care quality through the delivery of person-centered and family-oriented services, for patients of all ages and across disease stages, care settings, and specialties. While aging Baby Boomers are increasing the proportion of patients in the Medicare population over time, the sickest and most vulnerable patients needing health system support and other services to meet their complex needs can be found across the age spectrum and in a broad range of care settings, from perinatal care to geriatric care.
Pain Management and the Opioid Epidemic: Balancing ...
Released: July 13, 2017
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016.
The Challenge of Treating Obesity and Overweight ...
Released: July 12, 2017
The Roundtable on Obesity Solutions of the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine held a workshop in Washington, DC, on April 6, 2017, titled “The Challenge of Treating Obesity and Overweight: A Workshop.” The workshop discussions covered treatments for obesity, overweight, and severe obesity in adults and children; emerging treatment opportunities; the development of a workforce for obesity treatments; payment and policy consid- erations; and promising ways to move forward. This Proceedings of a Workshop–in Brief highlights key points made by workshop participants during the presentations and discussions. It is not intended to provide a comprehensive summary of information shared during the workshop.
Enabling Precision Medicine: The Role of Genetics in Clinical ...
Released: July 10, 2017
Those involved in the drug development process face challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical trial designs that enroll participants based on their genetics represent a potentially disruptive change that could improve patient outcomes, reduce costs associated with drug development, and further realize the goals of precision medicine. On March 8, 2017, the Forum on Drug Discovery, Development, and Translation and the Roundtable on Genomics and Precision Health hosted the workshop Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development.
Engaging the Private Sector and Developing Partnerships to ...
Released: June 27, 2017
In September 2016, the Sustainable Development Goals (SDGs) were adopted at the United Nations (UN) Development Summit to serve as a 15-year plan of action for all countries and people. Since the announcement of the SDGs, countries have been mapping out their national action plans, updating health and development information, reviewing national priorities, assessing the focus of current international development assistance, and determining which policies, laws, and strategies are already aligned with SDG targets and what changes are needed. In this process, many public and private entities are identifying opportunities for greater alignment and effectiveness in reaching their goals through partnerships. Considering this context, the Forum on Public–Private Partnerships for Global Health and Safety (PPP Forum) convened a workshop series to examine opportunities for the private sector to engage in partnerships to advance health and the SDGs.